Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in CGTX — Cognition Therapeutics Inc

CIK 1214717 BOSTON, MA
Back to CGTX Full portfolio

Position in CGTX

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$1,046,506
+$347,149 QoQ
Shares Held
910,006
-1.1% QoQ
Ownership
0.957%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#6
of 66 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CGTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,482,949 across 521 Biotechnology names. CGTX ranks #315 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in CGTX

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,046,506 910,006
2026-03-31 $699,357 920,208
2025-12-31 $1,179,837 873,954
2025-09-30 $962,180 712,727
2025-06-30 $114,302 368,720
2025-03-31 $155,331 368,961
2024-12-31 $246,995 352,348
2024-09-30 $151,788 323,643
2024-06-30 $406,312 244,767
2024-03-31 $337,056 185,196
2023-12-31 $323,376 174,798
2023-09-30 $251,709 174,798
2023-06-30 $322,991 176,498
2023-03-31 $242,744 122,598
2022-12-31 $257,455 122,598
2022-09-30 $152,777 80,409
2022-06-30 $32,010 15,171
2022-03-31 $37,746 13,726